Received Mar 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | LX2496 | — |
Kinrix - Under age use/they administered 3 doses of Kinrix to 3 different patients who are less than 4 years old.; Inappropriate schedule of vaccine administered/Kinrix 3rd dose Dtap; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 1-year-old female patient who received DTPa-IPV (Kinrix) (batch number LX2496) for prophylaxis. Previously administered products included Kinrix (received 1st dose) and Dtap (received 2 doses of Dtap on an unknown date). On an unknown date, the patient received the 3rd dose of Kinrix. On an unknown date, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Kinrix - Under age use/they administered 3 doses of Kinrix to 3 different patients who are less than 4 years old.) and inappropriate schedule of vaccine administered (Verbatim: Inappropriate schedule of vaccine administered/Kinrix 3rd dose Dtap). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-FEB-2026 The reporter asked that there were any safety concerns. The reporter did not share the expiration date of the dose or more details. This case is linked with US2026026429 and US2026026562, reported by same reporter for different patients.; Sender's Comments: US-GSK-US2026026562:Same reporter/Different patient US-GSK-US2026026429:Same reporter/Different patient